The following was received from the licensee via email:
Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, which holds Permit Number 13-00694-03 under the VA master materials license, reported discovery of a medical event to NHPP [VA National Health Physics Program] at approximately 1045 EDT, July 14, 2021. A Y-90 microsphere therapy administration for liver cancer was performed on July 14, 2021. The dosage was intended for two segments of the left lobe of the liver. Post implant surveys of the administration set found an elevated amount of Y-90 present. Measurements and calculations indicated the patient had received about 63 percent of the prescribed activity. The patient has been notified. There is no expectation at this time of harm to the patient.
NHPP will follow up with a written report in accordance with NRC requirements in 10 CFR 35.3045. NHPP has notified our NRC Region III Project Manager, Bryan Parker.
This event is reportable pursuant to 10 CFR 35.3045.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.